Home › Therapeutic areas › GI/Hepatology › Inflammatory Bowel Disease

Inflammatory Bowel Disease (3 companies)

Companies with an active program in Inflammatory Bowel Disease.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
ABSI Absci DermatologyGI/Hepatology+1 1 Phase 1 $1.31B 6
IRON Disc Medicine GI/HepatologyHematology+2 Rare 1 Phase 3 $3.49B 9
MESO Mesoblast CardiovascularGI/Hepatology+2 Rare 1 Approved $1.54B 5